United States securities and exchange commission logo





                 April 22, 2022

       Emmanuel Krakaris
       President, Chief Executive Officer
       Augmedix, Inc.
       111 Sutter Street, Suite 1300
       San Francisco, California 94104

                                                        Re: Augmedix, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed April 15,
2022
                                                            File No. 333-264337

       Dear Mr. Krakaris:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

              Please contact Janice Adeloye at 202-551-3034 or Katherine Bagley
at 202-551-2545
       with any questions.




                 Sincerely,


                 Division of Corporation Finance

                 Office of Trade & Services
       cc:                                              John M. Rafferty